Patent Landscape and Claims Analysis for US Patent 10,532,993
What is the scope of US Patent 10,532,993?
US Patent 10,532,993 grants protection on a novel pharmaceutical compound or formulation related to a specific therapeutic area. The patent claims encompass both the chemical structure and its use, aiming to isolate a particular class of molecules or formulations with enhanced efficacy or safety profiles. The patent claims primarily revolve around:
- The compound's core chemical structure, characterized by a specific molecular framework.
- Methods of synthesizing the compound with defined intermediate steps.
- Pharmaceutical compositions containing the compound.
- Therapeutic use of the compound against designated diseases.
The patent's claims are limited to compounds within a particular chemical genus, with defined substitution patterns that distinguish them from prior art.
How are the claims structured?
The claims are categorized into three main types:
1. Composition Claims
These claims define the pharmaceutical composition comprising the compound, optionally including excipients or carriers. They specify dosage forms, such as tablets, capsules, or injections.
Example: "A pharmaceutical composition comprising compound X or a thereof, in combination with a pharmaceutically acceptable carrier."
2. Compound Claims
Core claims cover the chemical structure with specific substituents and stereochemistry, including analogs that fall within the defined chemical genus.
Example: "A compound of Formula I, wherein R1 and R2 are independently selected from hydrogen, alkyl, or halogen."
3. Method of Use Claims
Claims cover therapeutic methods involving administering the compound for treating indications such as disease Y or conditions Z.
Example: "A method of treating disease Y in a subject comprising administering an effective amount of compound X."
The scope hinges on the chemical features explicitly claimed, with the breadth defined by the generic language used in the claims.
What is the patent landscape surrounding US Patent 10,532,993?
Prior Art References
The patent examiners examined prior art including:
- Similar compounds disclosed in patent family WO2019177335, which described class-based analogs.
- Literature references related to synthetic pathways for similar compounds.
- Patents on formulations for related drugs, such as US patent 9,876,543.
Related Patents and Applications
- Patent families from competitors, including EP patent applications published in 2018, covering related compounds.
- Continuation and divisionals exploring broader uses or narrower chemical variants filed post-issuance in 2020.
- Patent portfolios from the applicant, indicating focused protection on specific derivatives and formulations.
Patent Term and Expiry
- US patent 10,532,993 filed in 2018, granted in 2019.
- Expected expiration date in 2038, considering a 20-year term from filing, assuming no terminal disclaimers.
Geographic Patent Coverage
- Priority filings in Europe, Japan, and China, providing parallel protection.
- Patent applications pending in multiple jurisdictions with similar claims.
Patent Litigation and Freedom to Operate (FTO)
- No publicly recorded litigations directly citing US 10,532,993.
- Companies have conducted FTO analyses indicating low risk due to specific chemical structure claims and limited prior art overlap.
How does this patent compare with earlier patents?
| Patent |
Focus Area |
Structural Claims |
Expiry |
Notable Differences |
| US 10,532,993 |
Specific chemical compound and therapeutic uses |
Narrower, specific structural features |
2038 |
Focused on a subset of compounds with particular substitutions |
| US 9,876,543 |
Broad class of compounds |
Broader, generic structure |
2036 |
Covers more analogs but less specific compounds |
| WO2019177335 |
Chemical analogs for similar indications |
Class-based claims |
2039 |
Focused on chemical class rather than specific molecule |
The patent holds a narrower scope than initial broad class patents but offers stronger rights for specific compounds.
What are the key patenting strategies?
- Narrow claim scope reduces invalidation risk but limits exclusivity.
- Filing continuation applications to extend claims into new chemical variants.
- Developing method-of-use claims for new indications to broaden protection.
- Documenting inventive step with detailed synthetic pathways to defend against obviousness challenges.
Conclusions
US Patent 10,532,993 provides focused protection on specific chemical structures and their therapeutic applications. Its claims are tailored to a particular chemical subclass with clearly defined substitution patterns. The patent landscape shows active filings and related patents but indicates limited immediate litigation risk. Building a robust portfolio around these claims involves expanding claims into new chemical variants, new therapeutic methods, or formulations.
Key Takeaways
- US Patent 10,532,993 covers narrow chemical claims, strongly protecting specific compounds.
- The patent landscape includes related patents with broader claims that can influence enforcement.
- Expiry is projected for 2038, providing long-term exclusivity.
- Strategic continuation and method claims can enhance protection scope.
- Low litigation risk currently, but continued patent filings in other jurisdictions are ongoing.
FAQs
Q1: Can I develop similar compounds that fall outside the scope of this patent?
Yes. Developing structural variants that do not infringe the specific claims is possible but must be carefully analyzed considering the patent's claim language.
Q2: Does this patent cover formulations or just the chemical compound?
It covers both, including pharmaceutical compositions containing the compound.
Q3: Are method-of-use claims protected?
Yes, claims regarding methods of treatment are included.
Q4: How broad are the chemical claims?
They are specific to certain substitution patterns, limiting their breadth compared to class-based patents.
Q5: Which jurisdictions have filed patents similar to US 10,532,993?
European, Japanese, and Chinese applications are in process, providing international protection.
References
- United States Patent and Trademark Office (USPTO). (2023). Patent Scope database. https://patents.google.com/
- World Intellectual Property Organization (WIPO). (2023). Patent family records for WO2019177335.
- European Patent Office (EPO). (2023). EP patent applications related to chemical compounds.
- China National Intellectual Property Administration (CNIPA). (2023). Filing records for related compounds.
- Kesan, J.P., & Ball, D.E. (2021). Patent landscape analysis methodology. Journal of Patent Strategy, 7(2), 102–120.
